Ceftin and Thorazine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ceftin (cefuroxime axetil) and Thorazine (chlorpromazine hydrochloride). Common drug interactions include drug hypersensitivity among females and bronchopulmonary aspergillosis among males.
The phase IV clinical study analyzes what interactions people have when they take Ceftin and Thorazine. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.
What is Ceftin?
Ceftin has active ingredients of cefuroxime axetil. It is often used in sinusitis. eHealthMe is studying from 4,333 Ceftin users. Check the latest studies of Ceftin.
What is Thorazine?
Thorazine has active ingredients of chlorpromazine hydrochloride. It is often used in bipolar disorder. eHealthMe is studying from 3,237 Thorazine users. Check the latest studies of Thorazine.
22 people who take Ceftin and Thorazine together, and have interactions are studied.

What are the common drug interactions of Ceftin and Thorazine, by gender? *:
female:
- Drug hypersensitivity
- Conjunctival abrasion (injury to outer surface of eye)
- Dizziness
- Exostosis (formation of new bone on the surface of a bone)
- Furuncle (infection of the hair follicle)
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Melaena (the passage of black, tarry stools)
- Neck pain
- Neuropathy peripheral (surface nerve damage)
- Otitis externa (external ear infection)
male:
- Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
- Febrile neutropenia (fever with reduced white blood cells)
- Rhinovirus infection
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Syncope (loss of consciousness with an inability to maintain postural tone)
- Tachycardia (a heart rate that exceeds the range of 100 beats/min)
- Upper respiratory tract infection
- White blood cell count decreased
- Pneumonia
- Ejection fraction decreased (systolic heart failure)
What are the common drug interactions of Ceftin and Thorazine, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Chronic kidney disease
- Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
- Headache (pain in head)
- Nausea (feeling of having an urge to vomit)
50-59:
- Conjunctival abrasion (injury to outer surface of eye)
- Dizziness
- Exostosis (formation of new bone on the surface of a bone)
- Furuncle (infection of the hair follicle)
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Melaena (the passage of black, tarry stools)
- Neck pain
- Neuropathy peripheral (surface nerve damage)
- Otitis externa (external ear infection)
- Presbyopia (a condition in which the lens of the eye loses its ability to focus, making it difficult to see objects up close)
60+:
- Drug hypersensitivity
- Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
- Pulmonary oedema (fluid accumulation in the lungs)
- Rhinovirus infection
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Syncope (loss of consciousness with an inability to maintain postural tone)
- Tachycardia (a heart rate that exceeds the range of 100 beats/min)
- Upper respiratory tract infection
- White blood cell count decreased
- Febrile neutropenia (fever with reduced white blood cells)
What are the existing conditions these people have? *
- Restless Leg Syndrome (a powerful urge to move your legs): 4 people, 18.18%
- Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 18.18%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 9.09%
- Depression: 2 people, 9.09%
- Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 2 people, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Ceftin and Thorazine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Ceftin and Thorazine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ceftin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Thorazine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ceftin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Thorazine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Sahoo HB, Rath B, Behera JP, Moharana CS, "Cefuroxime axetil associated oral eruption: A case report", Apollo Medicine, 2016 Jun .
- Sahoo HB, Rath B, Behera JP, Moharana CS, "Cefuroxime axetil associated oral eruption: A case report", Apollo Medicine, 2016 Jun .
How the study uses the data?
The study uses data from the FDA. It is based on cefuroxime axetil and chlorpromazine hydrochloride (the active ingredients of Ceftin and Thorazine, respectively), and Ceftin and Thorazine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Bendamustine cause Adverse Event? - 2 seconds ago
- Could Tri-Luma cause Skin Irritation? - 21 seconds ago
- Drug interactions of Amitriptyline Hydrochloride and Aminophylline - 29 seconds ago
- Could Hytrin cause Blood Sodium Decreased? - 39 seconds ago
- Drug interactions of Chloramphenicol and Clenil - 55 seconds ago
- Drug interactions of Montelukast Sodium and Excedrin - a minute ago
- Nasal Congestion and Bacterial Infection - a minute ago
- Gout and Eczema - a minute ago
- Gout and Dermatitis - Atopic - a minute ago
- Could Kenalog cause Blood Alkaline Phosphatase Increased? - a minute ago